Ariharasivakumar Ganesan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ariharasivakumar Ganesan has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Muthiah Chellappandian
Division of Biopesticides and Environmental Toxicology, Sri Paramakalyani Centre for Excellence in Environmental Sciences, Manonmaniam Sundaranar University, Tirunelveli, India
3 shared publications Patrick A. Kalona
Centre for Research and Development, PT. Phytochemindo Reska, Bogor, West Java, Indonesia
3 shared publicationsUma Sundaresan
Department of Food Process Engineering, School of Bioengineering, SRM University, Kattankulathur, Tamil Nadu, India
3 shared publications
Latest Publications
- Open Access
- 18 March 2025
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
Curcuma xanthorrhiza Rhizome Extract Attenuates the Complete Freund’s Adjuvant-induced Rheumatoid Arthritis in Rats
Background: Rheumatoid arthritis (RA) affects nearly 4% of the world’s population, along with an increasing rate of new cases. Purpose: The current work was focused on investigating the anti-arthritic efficacy of the Curcuma xanthorrhiza rhizome extract (CXRE) against the complete Freund’s adjuvant (CFA)-triggered RA in rats. Methods: The RA was triggered in the experimental rats and then administered with CXRE, respectively, for 14 days. The body weight and paw edema of the rats were measured precisely. The levels of hematological biomarkers were measured using an automated hematological analyzer. The kidney injury biomarkers level was assessed using assay kits. The status of total protein and oxidative stress biomarkers was measured using kits. Histopathological studies were done on the hind limb tissues. Results: The treatment with the CXRE improved body weight and diminished paw edema in the CFA-triggered RA rats. The C-reactive protein and rheumatoid factor levels were appreciably attenuated by the CXRE treatment. A substantial reduction in renal markers was observed in the CXRE-treated RA rats. The CXRE increased the red blood cells and hemoglobin while reducing the white blood cell and erythrocyte sedimentation rate status in the RA rats. The antioxidants catalase, glutathione peroxidase, and superoxide dismutase were boosted, and lipid peroxidation status was depleted by the CXRE in the RA rats. The CXRE also ameliorated the CFA-induced histological alterations in the CFA-induced RA rats. Conclusion: In conclusion, the current results demonstrated that the CXRE appreciably attenuated the CFA-induced RA progression in the experimental rats via its potential antioxidant and salutary properties. Therefore, it could be utilized as a promising anti-arthritic agent to treat RA.
- 18 March 2025
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
Open AccessCurcuma xanthorrhiza Rhizome Extract Attenuates the Complete Freund’s Adjuvant-induced Rheumatoid Arthritis in Rats
Background: Rheumatoid arthritis (RA) affects nearly 4% of the world’s population, along with an increasing rate of new cases. Purpose: The current work was focused on investigating the anti-arthritic efficacy of the Curcuma xanthorrhiza rhizome extract (CXRE) against the complete Freund’s adjuvant (CFA)-triggered RA in rats. Methods: The RA was triggered in the experimental rats and then administered with CXRE, respectively, for 14 days. The body weight and paw edema of the rats were measured precisely. The levels of hematological biomarkers were measured using an automated hematological analyzer. The kidney injury biomarkers level was assessed using assay kits. The status of total protein and oxidative stress biomarkers was measured using kits. Histopathological studies were done on the hind limb tissues. Results: The treatment with the CXRE improved body weight and diminished paw edema in the CFA-triggered RA rats. The C-reactive protein and rheumatoid factor levels were appreciably attenuated by the CXRE treatment. A substantial reduction in renal markers was observed in the CXRE-treated RA rats. The CXRE increased the red blood cells and hemoglobin while reducing the white blood cell and erythrocyte sedimentation rate status in the RA rats. The antioxidants catalase, glutathione peroxidase, and superoxide dismutase were boosted, and lipid peroxidation status was depleted by the CXRE in the RA rats. The CXRE also ameliorated the CFA-induced histological alterations in the CFA-induced RA rats. Conclusion: In conclusion, the current results demonstrated that the CXRE appreciably attenuated the CFA-induced RA progression in the experimental rats via its potential antioxidant and salutary properties. Therefore, it could be utilized as a promising anti-arthritic agent to treat RA.
- Open Access
- 9 December 2024
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 16 (2) , 185-192
Immunomodulatory Effects of Andrographis paniculata Leaf Extract in Cyclophosphamide-induced Immunosuppressed Mice
Background: Cyclophosphamide is one of the most extensively used chemotherapeutic drugs and is employed to treat several malignancies. Cyclophosphamide often comes with several unpleasant side effects. The primary negative consequence of cyclophosphamide in clinical chemotherapy is immunosuppression, which can lead to life-threatening complications. Objectives: The present work was dedicated to exploring the therapeutic effects of Andrographis paniculata against cyclophosphamide-induced immunosuppression in mice. Materials and Methods: The BALB/c mice were treated with 80 mg/kg of cyclophosphamide to achieve immunosuppression and treated with 250 and 500 mg/kg of A. paniculata extract. 10 mg/kg of levamisole was used as a standard drug. After the completion of the treatments, the body weights of the experimental animals were measured. The immune organs (spleen and thymus) were determined by standard methods. The levels of blood components were studied using an automated hematological analyzer. The macrophage phagocytic index, humoral response, and delayed immune response were studied by standard methods. The histopathological analysis was done on the heart, spleen, and thymus. Results: The treatment with 250 and 500 mg/kg of A. paniculata extract substantially increased the body weight and elevated the immune organ index in the immunosuppressed mice. The changes in the levels of hematological parameters were successfully modulated by A. paniculata . The levels of macrophage phagocytic index and delayed and humoral immune responses were boosted by the A. paniculata extract treatment in the immunosuppressed mice. The outcomes of histopathological analysis exhibited that the A. paniculata extract attenuated the cyclophosphamide-induced damage to the heart, thymus, and spleen tissues. Conclusion: The findings of the current work validate the immunomodulatory properties of A. paniculata extract in cyclophosphamide-induced immunosuppressed mice. Hence, it was clear that A. paniculata can be a talented immunomodulatory agent to treat immunological complications.
- 9 December 2024
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 16 (2) , 185-192
Open AccessImmunomodulatory Effects of Andrographis paniculata Leaf Extract in Cyclophosphamide-induced Immunosuppressed Mice
Background: Cyclophosphamide is one of the most extensively used chemotherapeutic drugs and is employed to treat several malignancies. Cyclophosphamide often comes with several unpleasant side effects. The primary negative consequence of cyclophosphamide in clinical chemotherapy is immunosuppression, which can lead to life-threatening complications. Objectives: The present work was dedicated to exploring the therapeutic effects of Andrographis paniculata against cyclophosphamide-induced immunosuppression in mice. Materials and Methods: The BALB/c mice were treated with 80 mg/kg of cyclophosphamide to achieve immunosuppression and treated with 250 and 500 mg/kg of A. paniculata extract. 10 mg/kg of levamisole was used as a standard drug. After the completion of the treatments, the body weights of the experimental animals were measured. The immune organs (spleen and thymus) were determined by standard methods. The levels of blood components were studied using an automated hematological analyzer. The macrophage phagocytic index, humoral response, and delayed immune response were studied by standard methods. The histopathological analysis was done on the heart, spleen, and thymus. Results: The treatment with 250 and 500 mg/kg of A. paniculata extract substantially increased the body weight and elevated the immune organ index in the immunosuppressed mice. The changes in the levels of hematological parameters were successfully modulated by A. paniculata . The levels of macrophage phagocytic index and delayed and humoral immune responses were boosted by the A. paniculata extract treatment in the immunosuppressed mice. The outcomes of histopathological analysis exhibited that the A. paniculata extract attenuated the cyclophosphamide-induced damage to the heart, thymus, and spleen tissues. Conclusion: The findings of the current work validate the immunomodulatory properties of A. paniculata extract in cyclophosphamide-induced immunosuppressed mice. Hence, it was clear that A. paniculata can be a talented immunomodulatory agent to treat immunological complications.
- Open Access
- 26 November 2024
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 16 (1) , 92-101
Red Rice DE 40 Alleviates High-fat Diet-induced Hyperlipemia by Lowering Lipid Profiles in Rats
Background: Hyperlipidaemia is characterised by an abnormal increase in one or more lipids in plasma, and is a major contributor to obesity, coronary heart disease, myocardial infarction, and stroke if they are not treated promptly. Objectives: In this study, we intended to discover the therapeutic actions of Red Rice DE 40 (RR DE 40) on high-fat diet (HFD)-induced rats. Materials and Methods: The experimental rats were fed with HFD for 90 days to initiate the hyperlipidaemia and subsequently treated with 250 and 500 mg/kg of RR DE 40 from 60th to 90 days. The body weight of the rats was measured regularly. After the scarification, the blood, liver, and adipose tissue specimens were collected for biochemical assays. The liver and adipose tissues were weighed properly. The levels of haematological indices were counted using a haemocytometer. The levels of biochemical markers and liver marker enzymes were assessed using standard methods. The levels of lipid profiles were determined by standard methods. The excised liver and adipose tissues were analysed microscopically by histopathological analysis. Results: RR DE 40 treatment effectively decreased the body weight gain in the HFD-induced rats. The liver and adipose tissue weight was also reduced by the RR DE 40 treatment. The changes in the haematological parameters such as RBC, WBC, Hb, monocytes, lymphocytes, and polymorphs were modulated by the RR DE 40 treatment on EG-induced rats. The levels of total protein, albumin, glucose, and urea and activities of SGOT and SGPT were substantially decreased by the RR DE 40 treatment. The RR DE 40 treatment also diminished the status of TC, TG, LDL, and VLDL in the HFD-treated rats. The findings of histopathological analysis also witnessed the therapeutic effects of RR DE 40. Conclusion: The findings of this work highlighted that RR DE 40 is effective in HFD-induced hyperlipidaemia, probably due to its lipid-lowering potential. Hence, it may be used for the treatment of hyperlipidaemia-associated diseases.
- 26 November 2024
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 16 (1) , 92-101
Open AccessRed Rice DE 40 Alleviates High-fat Diet-induced Hyperlipemia by Lowering Lipid Profiles in Rats
Background: Hyperlipidaemia is characterised by an abnormal increase in one or more lipids in plasma, and is a major contributor to obesity, coronary heart disease, myocardial infarction, and stroke if they are not treated promptly. Objectives: In this study, we intended to discover the therapeutic actions of Red Rice DE 40 (RR DE 40) on high-fat diet (HFD)-induced rats. Materials and Methods: The experimental rats were fed with HFD for 90 days to initiate the hyperlipidaemia and subsequently treated with 250 and 500 mg/kg of RR DE 40 from 60th to 90 days. The body weight of the rats was measured regularly. After the scarification, the blood, liver, and adipose tissue specimens were collected for biochemical assays. The liver and adipose tissues were weighed properly. The levels of haematological indices were counted using a haemocytometer. The levels of biochemical markers and liver marker enzymes were assessed using standard methods. The levels of lipid profiles were determined by standard methods. The excised liver and adipose tissues were analysed microscopically by histopathological analysis. Results: RR DE 40 treatment effectively decreased the body weight gain in the HFD-induced rats. The liver and adipose tissue weight was also reduced by the RR DE 40 treatment. The changes in the haematological parameters such as RBC, WBC, Hb, monocytes, lymphocytes, and polymorphs were modulated by the RR DE 40 treatment on EG-induced rats. The levels of total protein, albumin, glucose, and urea and activities of SGOT and SGPT were substantially decreased by the RR DE 40 treatment. The RR DE 40 treatment also diminished the status of TC, TG, LDL, and VLDL in the HFD-treated rats. The findings of histopathological analysis also witnessed the therapeutic effects of RR DE 40. Conclusion: The findings of this work highlighted that RR DE 40 is effective in HFD-induced hyperlipidaemia, probably due to its lipid-lowering potential. Hence, it may be used for the treatment of hyperlipidaemia-associated diseases.